seperator

Information for Patients

seperator

seperator

Information for Patients

seperator

ETHRIS IS DEDICATED TO HELPING IMPROVE THE LIVES OF PATIENTS SUFFERING FROM SEVERE DISEASES.

We are a biotechnology company working on the research and development of novel mRNA-therapeutics. Our SNIM® RNA technology could have applications in many diseases, including metabolic and/or hereditary diseases, and in regenerative medicine. Our programs are all currently in the preclinical stage of development, which means that they have not yet been tested in humans.

Due to the highly regulated nature of our industry and in order to preserve patient safety, we cannot provide our products in development to patients. However, we endeavor, together with our pharmaceutical partners, to move our potential therapeutics forward into clinical studies so that they may become available for affected patients as soon as possible.

We regret that we are not able to provide more detail on the possible timelines and availability of SNIM® RNA therapeutics at this point.

We encourage you to stay informed about new developments in the field of SNIM® RNA therapeutics, and to stay in touch with us at www.ethris.com. We would also advise you to regularly speak to your doctor about new treatments that may become available.

Get in touch.

CONTACT